HR-6993-119
Placed on the Union Calendar, Calendar No. 735.
Sponsored by Jack Bergman (R-MI)
What it does
The bill would require the Secretary of Veterans Affairs to run two three-year grant programs for trials of neurorehabilitation treatments for chronic mild traumatic brain injury (mTBI) in veterans. Section 2 would cap grants at $5,000,000 per entity per fiscal year. Section 3 would require each year four pilot grants of up to $625,000 and five collaborative grants of up to $1,500,000, and the Secretary would seek an agreement with an independent organization to administer that program. Each section would authorize $10,000,000 per year for fiscal years 2026 through 2028, and the Secretary may use certain existing VA mental health and PTSD center funds if they supplement rather than replace other funds. The bill would also require reports to Congress and would change a date in the VA home loan fee table from June 9, 2034 to July 14, 2034.
Who benefits
Veterans with chronic mild TBI, who may gain access to trial-based treatments and related clinician training and outreach. Nonprofits, academic institutions, and non-VA health care providers with clinical trial capacity, which would be eligible for grants. Veterans' families, who would receive outreach, and VA clinicians, who could receive findings on treatments. Researchers studying non-drug therapies for mTBI would also gain a funding source.
Who is hurt
No group is clearly harmed. Taxpayers would bear up to $20 million per year in authorized spending over three years, subject to appropriation. Existing VA mental health and National Center for PTSD programs could see funds redirected if the Secretary uses available amounts, though the bill requires that use to supplement rather than replace other funds. Veterans in trials may face the risks of experimental treatments, and applicants not selected, or VA's own researchers, may compete for limited grant dollars. Grant recipients would bear reporting and compliance burdens.
Supporters argue
Supporters argue that mTBI is common among post-9/11 veterans and linked to depression, substance use, and suicide risk, yet few randomized trials exist for non-drug neurorehabilitation. They contend the bill is modest in scale, with a three-year sunset, a $5,000,000 cap per entity, required reporting on outcomes and adverse events, and an independent evaluator, which would produce evidence for VA care while protecting researchers' protocol independence.
Opponents argue
Opponents argue that VA already funds TBI and mental health research, and that new grants to outside entities could duplicate those efforts or divert limited VA mental health dollars. They contend the bill's allowance for using existing funds, outcome tracking that applies only if collected under each protocol, and limits on VA review of study design could weaken oversight of experimental treatments given to a vulnerable population.
Constitutional context
The bill rests on Congress's spending power and its power to provide for the armed forces and veterans under Article I, Section 8, with funds governed by the Appropriations Clause (Art. I, Section 9, cl. 7). It raises no significant constitutional question; the Supreme Court's spending power ruling in South Dakota v. Dole (1987) confirms Congress's broad authority to attach conditions to federal grants.
Checks and balances
Congress authorizes and limits the funding and requires reports, while the executive branch (VA Secretary) selects grantees and may suspend or terminate grants for noncompliance.